Yoji Murakami

707 total citations
25 papers, 310 citations indexed

About

Yoji Murakami is a scholar working on Surgery, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yoji Murakami has authored 25 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Immunology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yoji Murakami's work include Cancer Immunotherapy and Biomarkers (4 papers), Renal cell carcinoma treatment (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Yoji Murakami is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Renal cell carcinoma treatment (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Yoji Murakami collaborates with scholars based in Japan, United States and Romania. Yoji Murakami's co-authors include Takahisa Imamura, Yoshihiro Wada, Masatoshi Eto, Hidetoshi Nitta, Hideo Baba, Atsushi Irie, Yoshiaki Kawano, Ken Kikuchi, Yasuharu Nishimura and Masanori Shinohara and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and FEBS Letters.

In The Last Decade

Yoji Murakami

21 papers receiving 305 citations

Peers

Yoji Murakami
Jon Florence United States
Erinn S. Kellner United States
Joanna Grabowska Netherlands
Michele Smart United States
Yoji Murakami
Citations per year, relative to Yoji Murakami Yoji Murakami (= 1×) peers Thiago M. Steiner

Countries citing papers authored by Yoji Murakami

Since Specialization
Citations

This map shows the geographic impact of Yoji Murakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoji Murakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoji Murakami more than expected).

Fields of papers citing papers by Yoji Murakami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoji Murakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoji Murakami. The network helps show where Yoji Murakami may publish in the future.

Co-authorship network of co-authors of Yoji Murakami

This figure shows the co-authorship network connecting the top 25 collaborators of Yoji Murakami. A scholar is included among the top collaborators of Yoji Murakami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoji Murakami. Yoji Murakami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miki, Jun, Wataru Fukuokaya, Rikiya Taoka, et al.. (2024). Oncological outcomes of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: A nationwide multi‐institutional study. International Journal of Urology. 31(9). 1009–1016. 1 indexed citations
2.
Miura, Yuji, Takanobu Motoshima, Hiromu Yano, et al.. (2023). Predictive value of CXCL10 for the occurrence of immune‐related adverse events in patient with renal cell carcinoma. Microbiology and Immunology. 67(7). 345–354. 7 indexed citations
3.
Motoshima, Takanobu, Junji Yatsuda, Yoji Murakami, et al.. (2023). Sicca syndrome during ipilimumab and nivolumab therapy for metastatic renal cell carcinoma. IJU Case Reports. 6(2). 147–149. 2 indexed citations
4.
Pan, Cheng, Yukio Fujiwara, Yoshihiro Komohara, et al.. (2023). Dysfunction of sinus macrophages in tumor‐bearing host induces resistance to immunotherapy. Cancer Science. 115(1). 59–69. 6 indexed citations
5.
Motoshima, Takanobu, et al.. (2022). Efficacy of avelumab plus axitinib for advanced renal cell carcinoma as late-line therapy: A case report. Urology Case Reports. 45. 102198–102198.
6.
Murakami, Yoji, et al.. (2022). Nondistractive extraction of intracellular molecules from yeast using PEF‐assisted autolysis. Electrical Engineering in Japan. 215(1). 5 indexed citations
7.
Tanaka, Shinichi, et al.. (2022). Effects of pain-related catastrophic thinking, anxiety, and depression on pain intensity and quality of life in patients with knee and low back pain. Journal of Physical Therapy Science. 34(9). 625–629. 5 indexed citations
8.
Yatsuda, Junji, et al.. (2022). Subcapsular renal hematoma after ureterorenoscopy. IJU Case Reports. 5(4). 281–285. 1 indexed citations
9.
Komohara, Yoshihiro, Yuji Miura, Takuya F. Segawa, et al.. (2021). High T-cell infiltration in tumor tissue and younger age predict the response to pembrolizumab in recurrent urothelial cancer. Medical Molecular Morphology. 54(4). 316–323. 6 indexed citations
10.
Murakami, Yoji, et al.. (2021). Non-distractive Extraction of Intracellular Molecules from Yeast using PEF-assisted Autolysis. IEEJ Transactions on Fundamentals and Materials. 141(11). 615–621.
11.
Maeda, Yoshihiro, Yoshiaki Kawano, Yoshihiro Wada, et al.. (2015). C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways. Oncology Reports. 33(4). 1844–1850. 44 indexed citations
12.
Nitta, Hidetoshi, Yoji Murakami, Yoshihiro Wada, et al.. (2014). Cancer cells release anaphylatoxin C5a from C5 by serine protease to enhance invasiveness. Oncology Reports. 32(4). 1715–1719. 54 indexed citations
13.
Nitta, Hidetoshi, Yoshihiro Wada, Yoshiaki Kawano, et al.. (2013). Enhancement of Human Cancer Cell Motility and Invasiveness by Anaphylatoxin C5a via Aberrantly Expressed C5a Receptor (CD88). Clinical Cancer Research. 19(8). 2004–2013. 84 indexed citations
14.
Murakami, Yoji, Yoshihiro Wada, Hidetomo Kobayashi, et al.. (2012). The tail nick augments Aeromonas sobria serine protease (ASP) activity in plasma through retarding inhibition by α2‐macroglobulin. FEBS Letters. 586(20). 3613–3617. 1 indexed citations
15.
Wada, Yoshihiro, Mitsuhiro Uchiba, Yoshiaki Kawano, et al.. (2012). Severe bleeding tendency caused by a rare complication of excessive fibrinolysis with disseminated intravascular coagulation in a 51-year-old Japanese man with prostate cancer: a case report. Journal of Medical Case Reports. 6(1). 378–378. 9 indexed citations
16.
Irie, Atsushi, Yoji Murakami, Magdalena Nowak, et al.. (2010). Degradation of fibrinogen and collagen by staphopains, cysteine proteases released from Staphylococcus aureus. Microbiology. 157(3). 786–792. 61 indexed citations
17.
Murakami, Yoji, et al.. (2009). Pseudoaneurysm of the Superior Lateral Genicular Artery after Supracondylar Fracture of the Femur: A Case Report. Orthopedics & Traumatology. 58(4). 551–554. 1 indexed citations
18.
Mizuyama, Hajime & Yoji Murakami. (2008). 3203 Detailed Design of Manual Assembly Task for Anticipating Learning Effects. 2008(0). 53–54. 1 indexed citations
19.
Murakami, Yoji, et al.. (2004). Clinical Results of Arthroscopic Debridement of Pyogenic Arthritis of the Knee. Orthopedics & Traumatology. 53(1). 40–42.
20.
Ikeda, Tadashi, et al.. (1993). [A surgical case of cor triatriatum].. PubMed. 46(13). 1137–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026